LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Antibodies Interpreted after Scrub Typhus Infection

By LabMedica International staff writers
Posted on 25 Jun 2018
Print article
Image: Orientia tsutsugamushi (arrows) in culture of bronchoalveolar lavage fluid from a patient with acute respiratory distress syndrome (Photo courtesy of Aix Marseille Université).
Image: Orientia tsutsugamushi (arrows) in culture of bronchoalveolar lavage fluid from a patient with acute respiratory distress syndrome (Photo courtesy of Aix Marseille Université).
Scrub typhus is a zoonotic infection caused by the bacterium Orientia tsutsugamushi. It is transmitted to humans by the bite of the larval stage of trombiculid mites. With an annual incidence of about one million cases, it is an important challenge to public health in Southeast Asia.

The clinical presentation may vary from a mild febrile illness to a life-threatening disseminated infection with serious complications such as acute respiratory distress syndrome, hepatitis, renal failure, meningitis, and multiple organ failure, making the diagnosis difficult. The serological detection of IgM antibodies is the most widely used test to diagnose scrub typhus infection.

Scientists at the Christian Medical College (Vellore, India) included in this cross-sectional study, 203 patients over 18 years of age with previously confirmed scrub typhus. Scrub typhus was confirmed by positive immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) (optical density (OD) >0.8) and/or a positive polymerase chain reaction (PCR) for O. tsutsugamushi at a tertiary care teaching hospital in South India between December 2011 and March 2015.

The team performed ELISAs for IgM and IgG antibodies using the Scrub Typhus Detect kit (InBios International, Inc, Seattle, WA, USA). All patients had a positive IgM ELISA at diagnosis, of which 80 were confirmed by PCR. All patients had a blood sampling done during the study. Among them, eight patients had two blood samples taken at different time points. The time interval between confirmation of the original infection and study sample collection ranged from one month to 46 months. The overall trend showed a gradual fall in mean IgM levels over time, remaining above the threshold of positivity (OD >0.8) until 12 months after infection. The mean IgG levels showed a gradual rise, reaching a peak at 10 months post-infection, followed by a gradual decline, remaining above the cut-off threshold for more than 36 months.

The authors concluded that clinicians needed to be cautious in using a single serum sample for the detection of IgM to diagnose scrub typhus, as it remains elevated for up to 12 months after the infection, whereas the serum IgG level could be used as an indicator of past infection. The study was published in the June 2018 issue of the International Journal of Infectious Diseases.

Related Links:
Christian Medical College
InBios International
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.